Invention Grant
- Patent Title: Derivatives of resiquimod
-
Application No.: US17665104Application Date: 2022-02-04
-
Publication No.: US12077535B2Publication Date: 2024-09-03
- Inventor: Lihu Yang
- Applicant: Superb Wisdom Limited
- Applicant Address: WS Apia
- Assignee: SUPERB WISDOM LIMITED
- Current Assignee: SUPERB WISDOM LIMITED
- Current Assignee Address: WS Apia
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K45/06

Abstract:
A deuterated compound having structural formula I or a pharmaceutically acceptable salt thereof:
Values and example values of the variable in formula (I) are disclosed herein. Also disclosed are the use of compounds of formula (I) in the methods of treating a disease selected from cancer, an autoimmune disease, and an infectious disease, and methods of enhancing an immune response to an antigen.
Values and example values of the variable in formula (I) are disclosed herein. Also disclosed are the use of compounds of formula (I) in the methods of treating a disease selected from cancer, an autoimmune disease, and an infectious disease, and methods of enhancing an immune response to an antigen.
Public/Granted literature
- US20230002370A1 DERIVATIVES OF RESIQUIMOD Public/Granted day:2023-01-05
Information query